Investec maintains a "Buy" on Medplus Health Services, targeting Rs 940, citing growth plans and strong generics adoption. Mirae Asset Sharekhan upgrades Bajaj Finserv with a target of Rs 2,350, focusing on AI, profitable growth, and structural market opportunities. Hem Securities also recommends a "Buy" on Parag Milk, targeting Rs 255, driven by strong earnings, distribution, and value-added products.
